Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FRTX

Fresh Tracks Therapeutics (FRTX) Stock Price, News & Analysis

Fresh Tracks Therapeutics logo

About Fresh Tracks Therapeutics Stock (NASDAQ:FRTX)

Advanced Chart

Key Stats

Today's Range
$0.94
$0.94
50-Day Range
$0.94
$0.94
52-Week Range
$0.03
$1.03
Volume
2,402 shs
Average Volume
2,709 shs
Market Capitalization
$5.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresh Tracks Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FRTX Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Fresh Tracks Therapeutics Inc (FRTX)
See More Headlines

FRTX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Fresh Tracks Therapeutics investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), e.l.f. Beauty (ELF), Disc Medicine (IRON), Jabil (JBL) and Adobe (ADBE).

Company Calendar

Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:FRTX
CIK
819050
Web
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$10.06 million
Price / Sales
0.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.66 per share
Price / Book
0.56

Miscellaneous

Outstanding Shares
5,973,000
Free Float
5,959,000
Market Cap
$5.58 million
Optionable
Not Optionable
Beta
0.54
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:FRTX) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners